Salute e Benessere

UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund…

"We are thrilled to lead this record round for UroMems," said Jérôme Feraud, Head of Health Division at Crédit Mutuel Innovation. "Based on very positive data and feedback from patients and physicians in the pilot clinical trials, we strongly believe that the UroActive smart implant has the potential to become the standard of care as the next-generation SUI treatment." "We are thrilled to lead this record round for UroMems," said Jérôme Feraud, Head of Health…
PR Newswire
25/06/2024

Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools…

"Metabolon has a rich history of pioneering advancements in metabolomics. We are dedicated to empowering pharmaceutical and biotechnology companies, as well as academic and government institutions, with comprehensive metabolic insights to drive better health outcomes," said Ro Hastie, CEO of Metabolon. "With this NIH grant, Metabolon is poised to extend its expertise in T1D, aiming to enhance predictive capabilities and improve the lives of millions affected by this…
PR Newswire
25/06/2024

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the…

According to the GLOBOCAN 2020 statistics, breast cancer became the most common cancer in the world, with 2.31 million new cases and 0.67 million deaths. In China, there were 0.36 million new cases and 0.07 million deaths due to breast cancer, accounting for 15.5% and 11.2% of global cases. Amongst these, TNBC accounts for about 10% to 15% of all breast cancer cases, making TNBC a more aggressive type of cancer with a higher risk of recurrence and poor prognosis. Advanced TNBC is not...
Nasdaq GlobeNewswire
25/06/2024

SKAN, the Wellcome Sanger Institute and University of Newcastle to study early…

Researchers will work with leading LCH treating research centres worldwide to cover LCH driven by different genetic mutations with SKAN specifically creating a large cohort of Indian children for the study. The study comes at a time when researchers are still grappling with understanding how some genetic mutations that drive LCH result in lesions appearing in different parts of the body at different times. Researchers hope that the study will pave the way for better understanding the disease's…
PR Newswire
25/06/2024

ELFBAR earns multiple prestigious design awards worldwide

In 2024, ELFBAR celebrated its fifth anniversary with distinction, earning gold awards for its overall concept in communication design from both the American Good Design and the French Design Award. In 2024, ELFBAR celebrated its fifth anniversary with distinction, earning gold awards for its overall concept in communication design from both theAmerican Good Designand theFrench Design Award. The awards were given in response to a special souvenir bundle for the anniversary celebration...
PR Newswire
25/06/2024

Roborock Introduces Roborock Qrevo S: Robust Robotic Performance Meets…

The Roborock Qrevo S revolutionizes home cleaning with its fully automated, multifunctional dock. This advanced dock manages routine tasks efficiently, allowing you to focus on the more important aspects of life. It features a three-stage mop washing process - slow pre-wash, medium rinse, and high-speed spin drying, similar to that of a washing machine. The dock dynamically adjusts speed and water flow, ensuring high efficiency and convenience with minimal effort. The Roborock Qrevo S...
PR Newswire
25/06/2024

AMSilk to showcase its biofabricated yarns at Europe's largest trade show…

As the only Company to have succeeded in producing continuous filament yarns from spider silk proteins, AMSilk is now ready for commercialisation and the fair provides an important opportunity to showcase how the Company is redefining the boundaries of bio-based materials. As the only Company to have succeeded in producing continuous filament yarns from spider silk proteins, AMSilk is now ready for commercialisation and the fair provides an important opportunity to showcase how the Company is...
PR Newswire
25/06/2024

Insider Information: Nexstim Plc's offering for an EUR 750,000 convertible bond…

Company Announcement, Helsinki, 25 June 2024 at 9:30 AM (EEST) Insider Information: Nexstim Plc's offering for an EUR 750,000 convertible bond has closed and EUR 650,000 of the bond was subscribed for NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Nexstim Plc (NXTMH:HEX)...
Nasdaq GlobeNewswire
25/06/2024

Insider Information: Nexstim Plc launches an unsecured convertible bond offering…

Company Announcement, Helsinki, 25 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc launches an unsecured convertible bond offering of up to EUR 750,000 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Nexstim Plc (NXTMH:HEX) (“ Nexstim ” or the “ Company ”) announces...
Nasdaq GlobeNewswire
25/06/2024

NX Group Signs Strategic Partnership Agreement with Controlant of Iceland

Controlant's logo: https://kyodonewsprwire.jp/img/202406202471-O1-sXfsB050 Controlant's logo:https://kyodonewsprwire.jp/img/202406202471-O1-sXfsB050 NX's logo:https://kyodonewsprwire.jp/img/202406202471-O3-jlufE0EU Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202406202471/_prw_PI2fl_jHGSHe9r.png Headquartered inIceland, Controlant, a leading provider of real-time monitoring solutions for tracking temperature and location information during transport,...
PR Newswire
25/06/2024

Roche's OCREVUS subcutaneous administration approved by European Commission, as…

OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV) OCREVUS SC provides an additional treatment option without the need for IV facilities, expanding accessibility for patientsRoche is working closely with national health systems in Europe to ensure people with multiple sclerosis can access OCREVUS SC as quickly as possible Basel, 25 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY)...
Nasdaq GlobeNewswire
25/06/2024

RECOMMENDED CASH OFFER for MARIADB PLC by MERIDIAN BIDCO LLC which is an…

MANHATTAN BEACH, Calif., June 25, 2024 /PRNewswire/ -- On 24 May 2024, Meridian Bidco LLC ("Bidco") made an offer to acquire the entire issued and to be issued share capital of MariaDB plc ("MariaDB") (the "Offer") with the terms and conditions of the Offer set out in the offer document despatched and filed by Bidco as Exhibit (a)(1)(A) to the Tender Offer Statement and Rule 13e-3 Transaction Statement filed on Schedule TO with the US Securities and Exchange…
PR Newswire
25/06/2024

Psoriasis Market to Register Incremental Growth by 2034, Predicts DelveInsight |…

Key Takeaways from the Psoriasis Market Report Key Takeaways from the Psoriasis Market Report Discover which therapies are expected to grab major psoriasis market share @Psoriasis Market Report Psoriasis Overview Psoriasis is a chronic autoimmune skin condition characterized by the rapid growth of skin cells, leading to the formation of thick, red, scaly patches that can be itchy and sometimes painful. These patches, often referred to as plaques, commonly appear on the...
PR Newswire
24/06/2024

NABR Commends the IUCN's Decision to Reassess the Status of Long-Tailed Macaques

"NABR is pleased that the IUCN will reassess its designation of long-tailed macaques as 'Endangered'," said Matthew R. Bailey, president of NABR. "The IUCN's decision to uplist long tailed macaques to 'Endangered' in 2022 was not justified, nor supported by scientific information. NABR looks forward to working with the IUCN to ensure the scientific integrity of its processes." "NABR is pleased that the IUCN will reassess its designation of long-tailed macaques as…
PR Newswire
24/06/2024

Ultimovacs ASA announces revised terms of the employee share option program

Oslo, June 24, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, announces revised terms of the employee share option program. Ultimovacs has during the second quarter of this year implemented a cash preservation program that includes downsizing of the organization. As a measure to stimulate retention of non-redundant team members, the board of directors of Ultimovacs ASA has decided to revise the terms of...
Nasdaq GlobeNewswire
24/06/2024

Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing…

In 2024, Novo Nordisk plans to boost its current investments, aiming to allocate USD 6.8 billion towards production, a significant increase from the previous year's investment of USD 3.9 billion*.Bagsværd, Denmark, 24 June 2024– Novo Nordisk today announced plans to invest 4.1 billion US dollars (approx 27 billion Danish kroner) to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable...
Nasdaq GlobeNewswire
24/06/2024

Tecan appoints Mukta Acharya Head of the Life Sciences Business division

Tecan appoints Mukta Acharya Head of the Life Sciences Business divisionMännedorf, Switzerland, June 24, 2024 –The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya, currently serving as President, Tecan Americas, has been appointed the new Head of the Life Sciences Business division and a member of the Management Board of the Tecan Group. She is expected to assume her new position on August 1, 2024.Dr. Klaus Lun, Head of the Life Sciences Business since 2017...
Nasdaq GlobeNewswire
24/06/2024

EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP…

"These GMP certifications across our manufacturing sites in India and Malaysia reflect Biocon Biologics' continued compliance with the highest standards of quality and our unwavering commitment to addressing patient needs globally." - Company Spokesperson "These GMP certifications across our manufacturing sites inIndiaandMalaysiareflect Biocon Biologics' continued compliance with the highest standards of quality and our unwavering commitment to addressing patient needs globally...
PR Newswire
24/06/2024

Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in…

"The agreement with Orion to market and sell Flexilev in Europe represents a major milestone as part of the commercialization strategy for Flexilev. Since acquiring the product last year, we have identified several significant growth opportunities for Flexilev, with focus on signing an agreement for Europe where we already have sales in our home turf Scandinavia and marketing authorizations in several other countries. Orion has long-standing experience in the field of neurological diseases…
PR Newswire
24/06/2024

Artificial Intelligence (AI) in Healthcare Market to Grow at 38.2% CAGR by 2031…

Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/artificial-intelligence-in-healthcare-market Artificial Intelligence (AI) in Healthcare Market Overview: Segments covered in Artificial intelligence (AI) in healthcare Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/artificial-intelligence-in-healthcare-market Software to Remain Quintessential in...
PR Newswire
24/06/2024

Venous Thromboembolism Treatment Market to be Worth $4.40 Billion by 2030 -…

Venous thromboembolism occurs when a blood clot is formed in the veins of the arms or legs and moves through the bloodstream. It obstructs blood and oxygen flow, causing tissue and organ damage. Deep vein thrombosis and pulmonary embolism are both signs and symptoms of venous thromboembolism. These symptoms and the condition itself can be treated using certain devices such as thrombectomy devices, inferior vena cava filters, compression pumps, stockings, and other devices. Venous...
PR Newswire
24/06/2024

Thermal Cyclers Market Worth 1.86 Billion 2031- Exclusive Report by InsightAce…

Thermal Cyclers Market Report Scope: Thermal Cyclers Market Report Scope: Download Free Sample and ToC of the Report: https://www.insightaceanalytic.com/request-sample/2535 Thermal cyclers are essential tools in molecular biology research and diagnostics. They work by repeatedly heating and cooling a reaction mixture containing DNA, primers, DNA polymerase, and nucleotides. This cycling process allows the DNA to be replicated millions of times, creating copies of the target...
PR Newswire
24/06/2024

Transactions in Connection with Share Buy-back Program

Company Announcement COPENHAGEN, Denmark; June 24, 2024 – Genmab A/S (Nasdaq: GMAB).On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares.The share buy-back program is expected to be completed no later than December 16, 2024.The following transactions were executed under the program from June 17, 2024, to June 21, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)...
Nasdaq GlobeNewswire
24/06/2024

StickIt Technologies Inc Announces Reorganization in StickIt Thailand Ltd and…

"The world's cannabis industry is facing many challenges - which affects most companies in the industry and probably affects the share value. It is necessary to reduce costs and try to increase our technology sales worldwide. These actions will save the company about $120,000 CAD a year," concluded Eli Ben Haroosh, CEO of StickIt Technologies Inc. "The world's cannabis industry is facing many challenges - which affects most companies in the industry and probably affects the share…
PR Newswire
24/06/2024
Altri  Comunicati